141 related articles for article (PubMed ID: 17967429)
1. Oxidative DNA damage in polymorphonuclear leukocytes of patients with familial Mediterranean fever.
Kirkali G; Tunca M; Genc S; Jaruga P; Dizdaroglu M
Free Radic Biol Med; 2008 Feb; 44(3):386-93. PubMed ID: 17967429
[TBL] [Abstract][Full Text] [Related]
2. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.
Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S
Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091
[TBL] [Abstract][Full Text] [Related]
3. Familial mediterranean fever - a review and update.
Orbach H; Ben-Chetrit E
Minerva Med; 2001 Dec; 92(6):421-30. PubMed ID: 11740430
[TBL] [Abstract][Full Text] [Related]
4. Th1 polarization in familial Mediterranean fever.
Aypar E; Ozen S; Okur H; Kutluk T; Besbas N; Bakkaloglu A
J Rheumatol; 2003 Sep; 30(9):2011-3. PubMed ID: 12966607
[TBL] [Abstract][Full Text] [Related]
5. Activated phenotype of circulating neutrophils in familial Mediterranean fever.
Manukyan G; Petrek M; Kriegova E; Ghazaryan K; Fillerova R; Boyajyan A
Immunobiology; 2013 Jun; 218(6):892-8. PubMed ID: 23182715
[TBL] [Abstract][Full Text] [Related]
6. Heightened endotoxin susceptibility of monocytes and neutrophils during familial Mediterranean fever.
Davtyan TK; Harutyunyan VA; Hakobyan GS; Avetisyan SA
FEMS Immunol Med Microbiol; 2008 Apr; 52(3):370-8. PubMed ID: 18294193
[TBL] [Abstract][Full Text] [Related]
7. The effect of plasminogen activator inhibitor-1 -675 4G/5G polymorphism on familial Mediterranean fever (FMF) disease.
Ozel Demiralp D; Ekim M; Akar N
Clin Appl Thromb Hemost; 2009; 15(4):443-7. PubMed ID: 19033264
[TBL] [Abstract][Full Text] [Related]
8. Impaired endotoxin tolerance induction in patients with familial Mediterranean fever.
Davtyan TK; Hakopyan GS; Avetisyan SA; Mkrtchyan NR
Pathobiology; 2006; 73(1):26-39. PubMed ID: 16785765
[TBL] [Abstract][Full Text] [Related]
9. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
[TBL] [Abstract][Full Text] [Related]
10. [A respiratory splash of monocytes and neutrophils in familial Mediterranean fever].
Davtian TK; Avetisian SA; Akopian GS; Arutiunian VM
Ter Arkh; 2005; 77(12):39-43. PubMed ID: 16514818
[TBL] [Abstract][Full Text] [Related]
11. Regional mapping of the gene for familial Mediterranean fever on human chromosome 16p13.
Fischel-Ghodsian N; Bu X; Prezant TR; Oeztas S; Huang ZS; Bohlman MC; Rotter JI; Shohat M
Am J Med Genet; 1993 Jul; 46(6):689-93. PubMed ID: 8362911
[TBL] [Abstract][Full Text] [Related]
12. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
Livneh A
Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
[TBL] [Abstract][Full Text] [Related]
13. Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps.
Skendros P; Chrysanthopoulou A; Rousset F; Kambas K; Arampatzioglou A; Mitsios A; Bocly V; Konstantinidis T; Pellet P; Angelidou I; Apostolidou E; Ritis D; Tsironidou V; Galtsidis S; Papagoras C; Stakos D; Kouklakis G; Dalla V; Koffa M; Mitroulis I; Theodorou I; Ritis K
J Allergy Clin Immunol; 2017 Nov; 140(5):1378-1387.e13. PubMed ID: 28342915
[TBL] [Abstract][Full Text] [Related]
14. Increased procoagulant response of monocytes from patients with familial Mediterranean fever.
Courillon-Mallet A; Bevilacqua M; Wautier JL; Dervichian M; Cattan D; Caen J
Thromb Haemost; 1986 Oct; 56(2):211-3. PubMed ID: 3810556
[TBL] [Abstract][Full Text] [Related]
15. [Familial Mediterranean fever: an ancient hereditary disease].
Nucera G; La Regina M; Diaco M; Neri G; Gasbarrini G; Manna R
Ann Ital Med Int; 2003; 18(3):136-48. PubMed ID: 14621424
[TBL] [Abstract][Full Text] [Related]
16. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever.
Lidar M; Yaqubov M; Zaks N; Ben-Horin S; Langevitz P; Livneh A
J Rheumatol; 2006 Jun; 33(6):1089-92. PubMed ID: 16755655
[TBL] [Abstract][Full Text] [Related]
17. Triggers for attacks in familial Mediterranean fever: application of the case-crossover design.
Yenokyan G; Armenian HK
Am J Epidemiol; 2012 May; 175(10):1054-61. PubMed ID: 22234484
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation in patients with Familial Mediterranean Fever.
Coban E; Adanir H
Platelets; 2008 Sep; 19(6):405-8. PubMed ID: 18925507
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of familial Mediterranean fever: an Italian overview.
Manna R; Cerquaglia C; Curigliano V; Fonnesu C; Giovinale M; Verrecchia E; Montalto M; De Socio G; Soriano A; La Regina M; Gasbarrini G
Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():51-3. PubMed ID: 19530512
[TBL] [Abstract][Full Text] [Related]
20. Familial Mediterranean fever in northwest of Iran (Ardabil): the first global report from Iran.
Salehzadeh F; Emami D; Zolfegari AA; Yazdanbod A; Habibzadeh S; Bashardost B; Barak M; Feizi I; Azimi H; Jastan M; Khalafi J
Turk J Pediatr; 2008; 50(1):40-4. PubMed ID: 18365590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
